Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
NGO

Cancer Research UK

Tracked across 35 events · 498 articles · First seen May 18, 2025 · Last active Sep 17, 2026

Sentiment
21
Attention
7
Events
35
Relationships
16
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 80
Tech
Impact: Cancer Research UK>>> funded the scientists who developed this groundbreaking urine test, playing a crucial role in advancing lung cancer detection and treatment.
May 25, 2026 · 7 articles
7 70
Tech
Impact: The Cancer Research UK funded the study, demonstrating its commitment to cancer prevention and research, and highlighting the success of public health initiatives.
Jun 17, 2026 · 30 articles
4 10
Tech
Impact: The Cancer Research UK funded the study, supporting the research into diet and cancer risk.
Feb 27, 2026 · 7 articles
6 60
Tech
Impact: Cancer Research UK>>> has backed the development of the mRNA-4194 vaccine, providing support and funding for the research, which aligns with its mission to prevent cancer.
Jun 08, 2026 · 6 articles
2 10
Tech
Impact: Funded the study and highlighted the limitations of the current self-presentation approach, advocating for more personalized care and further research on implementation.
Aug 04, 2026 · 6 articles
4 65
Tech
A study published in European Urology Oncology, led by the University of Birmingham and diagnostics company Nonacus, found that the GALEAS Bladder urine test detected 92% of bladder cancers in a real-world NHS trial involving…
Impact: Provided early funding for the test's development and receives royalty payments. The success supports its mission and may encourage further investment in similar technologies.
Sep 02, 2026 · 6 articles
1 0
Tech
Impact: Provided commentary on the link and prevention advice, reinforcing public health messaging.
Aug 20, 2026 · 6 articles
3 0
Domestic
Impact: Cancer Research UK, through its chief executive Michelle Mitchell, has highlighted the unacceptable delays in cancer treatment and called for more investment in the United Kingdom — National Health Service workforce and equipment.
Feb 24, 2026 · 6 articles
4 20
Domestic
Impact: Cancer Research UK>>> acknowledged that the decision on screening would be 'disappointing for some' but aligned with evidence regarding PSA test reliability.
Jun 02, 2026 · 6 articles
3 50
Regulatory
Impact: Cancer Research UK has campaigned for lung screening and supports the Lung Cancer Screening Programme, advocating for its nationwide rollout and adequate resources.
May 24, 2026 · 6 articles
1 10
Domestic
Impact: The charity expresses concern over low uptake and calls for more action.
Jul 10, 2026 · 7 articles
2 40
Domestic
Impact: The charity endorsed the programme, seeing it as a step toward beating cervical cancer for everyone.
Aug 24, 2026 · 8 articles
0 0
Tech
Impact: Funder and partner in the International Alliance for Cancer Early Detection; supported the research and employs one co-author.
Aug 25, 2026 · 6 articles
2 5
Tech
A study published in Science on 10 September 2026 reveals that platinum-based chemotherapy, while life-saving for childhood cancer, causes extensive DNA damage in healthy cells, including a previously unknown pattern of damage in the liver.…
Impact: Funded the research; aligns with its goal to beat cancer.
Sep 10, 2026 · 6 articles
1 5
Tech
A new meta-analysis published in the Journal of the National Cancer Institute concludes that overdiagnosis in breast cancer screening is far lower than previously estimated. Led by Sisse Helle Njor of the University of Southern…
Impact: Funded senior researcher Matejka Rebolj, supporting the study's completion.
Sep 14, 2026 · 7 articles
6 50
Tech
Impact: Cancer Research UK provided statistics on cervical cancer and commented on the positive impact of pembrolizumab's availability.
Jun 25, 2026 · 6 articles
7 70
Tech
Impact: Cancer Research UK welcomed the findings of Daraxonrasib, noting its potential to give Pancreatic cancer patients more precious time.
May 29, 2026 · 74 articles
6 50
Tech
Impact: Cancer Research UK>>> welcomed the findings, reinforcing its mission to support cancer research and providing a positive endorsement of the vaccine's potential. Its statement helps raise public awareness and encourages further research.
Jun 01, 2026 · 6 articles
4 15
Regulatory
The United Kingdom — National Institute for Health and Care Research (NICE) reversed its July 2024 rejection of Enhertu (trastuzumab deruxtecan) and recommended the drug for routine NHS use in Bret Engemann for around 1,000…
Impact: The charity's research director highlighted trial evidence that Enhertu extends survival and delays disease progression.
Sep 16, 2026 · 7 articles
1 10
Tech
Impact: Co-funded the MRC Biomedical NMR Centre that supported the work.
Jul 09, 2026 · 6 articles
7 60
Tech
On August 19, 2026, Moderna and Merck announced that their personalized mRNA cancer vaccine, intismeran autogene, combined with Merck's immunotherapy Pembrolizumab, met its primary and secondary endpoints in a Phase 3 trial involving 1,137 patients…
Impact: Cancer Research UK commented on the promise of the vaccine and emphasized the need for continued funding. The organization may see increased donations and research interest.
Aug 19, 2026 · 126 articles
2 5
Tech
Researchers at Sanford Burnham Prebys, Mayo Clinic and international collaborators published findings in Nature (journal) on July 29, 2026, revealing a previously unknown mechanism linking dysfunctional mitochondria to chronic age-related inflammation. The study shows that…
Impact: Funded the study, reflecting its interest in cancer-adjacent inflammation biology.
Aug 20, 2026 · 6 articles
4 10
Accidents
Impact: Cancer Research UK is cited for statistics on prostate cancer, providing context on the prevalence of the disease in the UK.
Jun 17, 2026 · 34 articles
4 10
Tech
Impact: Cancer Research UK provided statistics on melanoma incidence in the UK, highlighting the global relevance of early detection technologies.
May 25, 2026 · 6 articles
6 20
Business
Impact: Cancer Research UK supported the initial development of Myricx Bio, playing a role in its early funding and establishment.
Jul 05, 2026 · 21 articles
4 0
Regulatory
Feb 13, 2026 · 7 articles
3 0
Regulatory
Feb 13, 2026 · 6 articles
1 0
Domestic
Mar 28, 2026 · 9 articles
4 0
Tech
Mar 09, 2026 · 6 articles
4 0
Domestic
May 14, 2026 · 6 articles
+ 5 more events View on Dashboard
ERGEN INTELLIGENCE
Track Cancer Research UK live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.